Since it has been reported that NANOG expression is controlled by Hif-1α and that they cooperate, promoting self-renewal in breast cancer stem cells [63], we therefore hypothesize that the GBM subgroup with HIF1A-KDM5C hyperactivity has a distinctive stemness expression signature. The gene discussed is HIF1A; the disease is breast carcinoma.